The Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin

Biofilm formation is an important virulence factor for the opportunistic microorganisms that elicit skin infections. The recalcitrant feature of biofilms and their antibiotic tolerance impose a great challenge on the use of conventional therapies. Most antibacterial agents have difficulty penetratin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yin-Ku Lin, Shih-Chun Yang, Ching-Yun Hsu, Jui-Tai Sung, Jia-You Fang
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/b33c97d732de4f6d938138c8897a10dd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b33c97d732de4f6d938138c8897a10dd
record_format dspace
spelling oai:doaj.org-article:b33c97d732de4f6d938138c8897a10dd2021-11-11T18:24:55ZThe Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin10.3390/molecules262163921420-3049https://doaj.org/article/b33c97d732de4f6d938138c8897a10dd2021-10-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6392https://doaj.org/toc/1420-3049Biofilm formation is an important virulence factor for the opportunistic microorganisms that elicit skin infections. The recalcitrant feature of biofilms and their antibiotic tolerance impose a great challenge on the use of conventional therapies. Most antibacterial agents have difficulty penetrating the matrix produced by a biofilm. One novel approach to address these concerns is to prevent or inhibit the formation of biofilms using nanoparticles. The advantages of using nanosystems for antibiofilm applications include high drug loading efficiency, sustained or prolonged drug release, increased drug stability, improved bioavailability, close contact with bacteria, and enhanced accumulation or targeting to biomasses. Topically applied nanoparticles can act as a strategy for enhancing antibiotic delivery into the skin. Various types of nanoparticles, including metal oxide nanoparticles, polymeric nanoparticles, liposomes, and lipid-based nanoparticles, have been employed for topical delivery to treat biofilm infections on the skin. Moreover, nanoparticles can be designed to combine with external stimuli to produce magnetic, photothermal, or photodynamic effects to ablate the biofilm matrix. This study focuses on advanced antibiofilm approaches based on nanomedicine for treating skin infections. We provide in-depth descriptions on how the nanoparticles could effectively eliminate biofilms and any pathogens inside them. We then describe cases of using nanoparticles for antibiofilm treatment of the skin. Most of the studies included in this review were supported by in vivo animal infection models. This article offers an overview of the benefits of nanosystems for treating biofilms grown on the skin.Yin-Ku LinShih-Chun YangChing-Yun HsuJui-Tai SungJia-You FangMDPI AGarticlebiofilmmicrobenanoparticleskininfectionresistanceOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6392, p 6392 (2021)
institution DOAJ
collection DOAJ
language EN
topic biofilm
microbe
nanoparticle
skin
infection
resistance
Organic chemistry
QD241-441
spellingShingle biofilm
microbe
nanoparticle
skin
infection
resistance
Organic chemistry
QD241-441
Yin-Ku Lin
Shih-Chun Yang
Ching-Yun Hsu
Jui-Tai Sung
Jia-You Fang
The Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin
description Biofilm formation is an important virulence factor for the opportunistic microorganisms that elicit skin infections. The recalcitrant feature of biofilms and their antibiotic tolerance impose a great challenge on the use of conventional therapies. Most antibacterial agents have difficulty penetrating the matrix produced by a biofilm. One novel approach to address these concerns is to prevent or inhibit the formation of biofilms using nanoparticles. The advantages of using nanosystems for antibiofilm applications include high drug loading efficiency, sustained or prolonged drug release, increased drug stability, improved bioavailability, close contact with bacteria, and enhanced accumulation or targeting to biomasses. Topically applied nanoparticles can act as a strategy for enhancing antibiotic delivery into the skin. Various types of nanoparticles, including metal oxide nanoparticles, polymeric nanoparticles, liposomes, and lipid-based nanoparticles, have been employed for topical delivery to treat biofilm infections on the skin. Moreover, nanoparticles can be designed to combine with external stimuli to produce magnetic, photothermal, or photodynamic effects to ablate the biofilm matrix. This study focuses on advanced antibiofilm approaches based on nanomedicine for treating skin infections. We provide in-depth descriptions on how the nanoparticles could effectively eliminate biofilms and any pathogens inside them. We then describe cases of using nanoparticles for antibiofilm treatment of the skin. Most of the studies included in this review were supported by in vivo animal infection models. This article offers an overview of the benefits of nanosystems for treating biofilms grown on the skin.
format article
author Yin-Ku Lin
Shih-Chun Yang
Ching-Yun Hsu
Jui-Tai Sung
Jia-You Fang
author_facet Yin-Ku Lin
Shih-Chun Yang
Ching-Yun Hsu
Jui-Tai Sung
Jia-You Fang
author_sort Yin-Ku Lin
title The Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin
title_short The Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin
title_full The Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin
title_fullStr The Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin
title_full_unstemmed The Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin
title_sort antibiofilm nanosystems for improved infection inhibition of microbes in skin
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/b33c97d732de4f6d938138c8897a10dd
work_keys_str_mv AT yinkulin theantibiofilmnanosystemsforimprovedinfectioninhibitionofmicrobesinskin
AT shihchunyang theantibiofilmnanosystemsforimprovedinfectioninhibitionofmicrobesinskin
AT chingyunhsu theantibiofilmnanosystemsforimprovedinfectioninhibitionofmicrobesinskin
AT juitaisung theantibiofilmnanosystemsforimprovedinfectioninhibitionofmicrobesinskin
AT jiayoufang theantibiofilmnanosystemsforimprovedinfectioninhibitionofmicrobesinskin
AT yinkulin antibiofilmnanosystemsforimprovedinfectioninhibitionofmicrobesinskin
AT shihchunyang antibiofilmnanosystemsforimprovedinfectioninhibitionofmicrobesinskin
AT chingyunhsu antibiofilmnanosystemsforimprovedinfectioninhibitionofmicrobesinskin
AT juitaisung antibiofilmnanosystemsforimprovedinfectioninhibitionofmicrobesinskin
AT jiayoufang antibiofilmnanosystemsforimprovedinfectioninhibitionofmicrobesinskin
_version_ 1718431845312364544